【レポートの概要（一部）】
Table of Contents
Chapter 1. Executive Summary
1.1. Pharmacovigilance– Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Pharmacovigilance Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Pharmacovigilance – Market dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Pharmacovigilance – PESTEL Analysis
2.6. Pharmacovigilance Company Market Share Analysis, 2013
Chapter 3. Pharmacovigilance Clinical Trial Phase Outlook
3.1. Pharmacovigilance market share, by clinical trial phase, 2013 & 2020
3.2. Preclinical
3.2.1. Preclinical Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3. Phase 0
3.3.1. Phase 0 Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.4. Phase I
3.4.1. Phase I Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.5. Phase II
3.5.1. Phase II Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.6. Phase III
3.6.1. Phase III Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.7. Phase IV
3.7.1. Phase IV Market Estimates and Forecasts, 2012 – 2020 (USD Million)
Chapter 4. Pharmacovigilance Type of Service Provider Outlook
4.1. Pharmacovigilance market share, by type of service provider, 2013 & 2020
4.2. In- House
4.2.1. In-House Market Estimates and Forecasts, 2012 – 2020 (USD Million)
4.3. Contract Outsourcing
4.3.1. Contract Outsourcing Market Estimates and Forecasts, 2012 – 2020 (USD Million)
Chapter 5. Pharmacovigilance Regional Outlook
5.1. Pharmacovigilance market share by region, 2012 & 2020
5.2. North America
5.2.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.2.2. Market Estimates and Forecasts, by Type of Service Provider
5.3. Europe
5.3.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.3.2. Market Estimates and Forecasts, by Type of Service Provider
5.4. Asia Pacific
5.4.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.4.2. Market Estimates and Forecasts, by Type of Service Provider
5.5. RoW
5.5.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.5.2. Market Estimates and Forecasts, by Type of Service Provider
Chapter 6. Competitive Landscape
6.1 Accenture Plc.
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Boehringer Ingelheim GmbH
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Bristol-Myers Squibb
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Clinquest Group B.V.
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Cognizant Technology Solutions Corporation
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Covance, Inc.
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 F. Hoffmann-La Roche Ltd
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 GlaxoSmithKline (GSK)
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 IBM Corporation
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 ICON, Plc
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 iGATE Corporation
6.11.1 Company Overview
6.11.2 Financial Performance
6.11.3 Product Benchmarking
6.11.4 Strategic Initiatives
6.12 iMEDGlobal Corporation
6.12.1 Company Overview
6.12.2 Financial Performance
6.12.3 Product Benchmarking
6.12.4 Strategic Initiatives
6.13 Infosys
6.13.1 Company Overview
6.13.2 Financial Performance
6.13.3 Product Benchmarking
6.13.4 Strategic Initiatives
6.14 Ipca Laboratories Ltd
6.14.1 Company Overview
6.14.2 Financial Performance
6.14.3 Product Benchmarking
6.14.4 Strategic Initiatives
6.15 Janssen Research & Development, LLC
6.15.1 Company Overview
6.15.2 Financial Performance
6.15.3 Product Benchmarking
6.15.4 Strategic Initiatives
6.16 Novartis International AG
6.16.1 Company Overview
6.16.2 Financial Performance
6.16.3 Product Benchmarking
6.16.4 Strategic Initiatives
6.17 PAREXEL International Corporation
6.17.1 Company Overview
6.17.2 Financial Performance
6.17.3 Product Benchmarking
6.17.4 Strategic Initiatives
6.18 Pfizer, Inc.
6.18.1 Company Overview
6.18.2 Financial Performance
6.18.3 Product Benchmarking
6.18.4 Strategic Initiatives
6.19 Pharmaceutical Product Development, Inc. (PPD, Inc.)
6.19.1 Company Overview
6.19.2 Financial Performance
6.19.3 Product Benchmarking
6.19.4 Strategic Initiatives
6.20 Sanofi Aventis
6.20.1 Company Overview
6.20.2 Financial Performance
6.20.3 Product Benchmarking
6.20.4 Strategic Initiatives
6.21 Synowlwedge LLC
6.21.1 Company Overview
6.21.2 Financial Performance
6.21.3 Product Benchmarking
6.21.4 Strategic Initiatives
6.22 Wipro Ltd.
6.22.1 Company Overview
6.22.2 Financial Performance
6.22.3 Product Benchmarking
6.22.4 Strategic Initiatives
6.23 PRA Health Sciences Inc.
6.23.1 Company Overview
6.23.2 Financial Performance
6.23.3 Product Benchmarking
6.23.4 Strategic Initiatives
6.24 Quantum Solutions India
6.24.1 Company Overview
6.24.2 Financial Performance
6.24.3 Product Benchmarking
6.24.4 Strategic Initiatives
6.25 Quintiles Transnational Corporation
6.25.1 Company Overview
6.25.2 Financial Performance
6.25.3 Product Benchmarking
6.25.4 Strategic Initiatives
6.26 inVentiv Health Inc.
6.26.1 Company Overview
6.26.2 Financial Performance
6.26.3 Product Benchmarking
6.26.4 Strategic Initiatives
6.27 OptumInsight, Inc.
6.27.1 Company Overview
6.27.2 Financial Performance
6.27.3 Product Benchmarking
6.27.4 Strategic Initiatives
6.28 United BioSource Corporation
6.28.1 Company Overview
6.28.2 Financial Performance
6.28.3 Product Benchmarking
6.28.4 Strategic Initiatives
6.29 Ecron Acunova
6.29.1 Company Overview
6.29.2 Financial Performance
6.29.3 Product Benchmarking
6.29.4 Strategic Initiatives
6.30 Fortitude Clinical
6.30.1 Company Overview
6.30.2 Financial Performance
6.30.3 Product Benchmarking
6.30.4 Strategic Initiatives
6.31 ITClinical
6.31.1 Company Overview
6.31.2 Financial Performance
6.31.3 Product Benchmarking
6.31.4 Strategic Initiatives
Chapter 7. Methodology and Scope
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources
List of Tables
1. Pharmacovigilance Market – Industry Summary & Critical Success Factors (CSFs)
2. Global Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020, Revenue (USD Million)
3. Global Pharmacovigilance Market Revenue, By Type of Service Provider , 2012 – 2020, Revenue (USD Million)
4. Global Pharmacovigilance Market Revenue, By Region, 2012 – 2020, Revenue (USD Million)
5. Pharmacovigilance Market – Key market driver analysis
6. Pharmacovigilance – Key market restraint analysis
7. North America Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
8. North America Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
9. North America Pharmacovigilance Market Revenue, By Type of Service provider, 2012 – 2020 (USD Million)
10. Europe Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
11. Europe Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
12. Europe Pharmacovigilance Market Revenue, By Type of service Provider, 2012 – 2020 (USD Million)
13. Asia Pacific Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
14. Asia Pacific Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
15. Asia Pacific Pharmacovigilance Market Revenue, By Type of service Provider, 2012 – 2020 (USD Million)
16. RoW Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
17. RoW Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
18. RoW Pharmacovigilance Market Revenue, By Type of Service Provider, 2012 – 2020 (USD Million)
List of Figures
1. Pharmacovigilance: Market Segmentation
2. Global Pharmacovigilance Market, 2012 – 2020, Revenue (USD Million)
3. Pharmacovigilance Market Dynamics
4. Key Opportunities Prioritized
5. Pharmacovigilance Market – Porter’s Analysis
6. Pharmacovigilance Market – PESTEL Analysis
7. Pharmacovigilance Company Market Share Analysis, 2013
8. Pharmacovigilance Market Share, By Clinical Trial Phase, 2013 & 2020
9. Pharmacovigilance Market Share, By Type of Service Provider, 2013 & 2020
10. Pharmacovigilance Market Share, By Region, 2013 & 2020
【レポート販売概要】
■ タイトル：医薬品の副作用調査の世界市場分析：臨床試験フェーズ別（前臨床試験、フェーズI / 1、フェーズII / 2、フェーズIII / 3、フェーズIV / 4試験）、サービス提供者別（自宅内、契約委託）、セグメント予測、-2020■ 英文：Pharmacovigilance Market Analysis By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial), By Type Of Service Providers (In House, Contract Outsourcing) And Segment Forecasts To 2020
■ 発行日：2015年2月15日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707656
■ 調査対象地域：グローバル
- 自動車用歯車の世界市場：遊星歯車、かさ歯車、ラック・アンド・ピニオン、ハイポイドギヤ、ウォームギヤ、ヘリカルギヤ、平歯車The global automotive gears market is projected to grow at a CAGR of 6.1% from 2015 to 2020. The market is estimated to be USD 28.47 Billion in 2015 and is projected to reach 38.27 Billion by 2020. Asia-Pacific is the largest market for automotive gears, followed by North America and Europe. The growth of the automotive gears market is fueled by increasing vehicle production, enhanced driving expe …
- 在宅医療の世界市場：コンポーネント別（サービス、機器）、地域別、セグメント予測The global home healthcare market size is anticipated to reach USD 557.57 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc. This growth can be attributed to improved patient outcome, cost-efficiency, and patient convenience provided by home healthcare. In addition, rising cases of diseases, such as dementia, Alzheimer’s, and orthopedic conditions, a …
- OMV Petrom SA：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013OMV Petrom SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary OMV Petrom SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operati …
- Monopile Foundation: Dominance in Offshore Wind Foundation IndustryMonopile Foundation: Dominance in Offshore Wind Foundation Industry Summary The global offshore wind power industry has grown rapidly in recent years. Countries looking to increase their dependency on wind energy are increasingly looking to offshore wind projects due to high capacity factors and high wind speeds. On the other hand, the increased distance from the shore also increases the water dep …
- アイデンティティ及びアクセス管理の世界市場2016-2020About IAM IAM is a security solution that confirms the accessibility of authorized resources in an IT system. In the mid-1990s, organizations struggled to meet the compliance demands because it was expensive. However, organizations have understood the compliance requirements and are focusing on comply with the set regulations. The key driver for the growth of IAM is the initiatives such as enforce …
- 変電所自動化の世界市場2015-2019About substation automation Substation automation is the upgrade or improvement of existing electrical substations. This includes incorporation of intelligent technologies and equipment, such as relational databases and advanced communication systems, into power grids. Automation of substations help electric utilities monitor and control the T and D processes of substations remotely, thus, ensurin …
- 世界のシェールガス産業における主要企業分析The extraction of oil and gas from shale formations is a relatively new phenomenon with commercial production only first occurring in the twenty-first century. Shale rock formations have low permeability and porosity and so require the use of horizontal drilling and hydraulic fracturing in order to extract the hydrocarbon resources. The techniques to develop hydrocarbons from shale formations was …
- French Hospital Hematology and Flow Cytometry Market 2014This new report from Venture Planning Group contains 231 pages, 13 tables, and presents a comprehensive analysis of the French hospital hematology and flow cytometry markets, including: Major issues pertaining to the French hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next te …
- 麻酔用気管内チューブ（ETT）の世界市場2016-2020About ETT ETT is a tube embedded into the trachea for the administration of anesthesia, maintenance of the airway passage, aspiration of secretions, ventilation of the lungs, and anticipation of the passageway of foreign material into the tracheobronchial tree. There are two types of ETT for anesthesia management: the orotracheal tube and the nasotracheal tube. The orotracheal tube is embedded thr …
- 電子棚札（ESL）の世界市場2017-2021About Electronic Shelf Labels An ESL is a system used by retailers to display the price of the product on the shelf and information related to it. An ESL is usually attached on the front edge of a retail shelf; it uses LCD or similar technology for displaying the product information. The product price displayed on an ESL is automatically updated whenever a price is changed. This change can be made …
- 世界の調達アウトソーシング市場動向（2012-2016）TechNavio's analysts forecast the Global Procurement Outsourcing market to grow at a CAGR of 23.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant cost reduction. The Global Procurement Outsourcing market has also been witnessing the changing pricing models. However, the lack of domain understanding could pose a challenge to the growt …
- 自動車サイバーセキュリティの世界市場：ネットワーク、エンドポイント、アプリケーション、無線、クラウドセキュリティThe global automotive cyber security market is projected to grow at a CAGR of 13.2% during the forecast period, to reach USD 31.8 Million by 2021 from an estimated USD 17.1 Million in 2016. The base year for the report is 2015 and the forecast year is 2021. Increasing connectivity of automobiles is one of the major factors driving the growth of the cyber security market. The OBD area of applicatio …
- 世界のCRBN（化学・生物・放射性物質・核）防衛市場動向2013-2023：市場規模及び成長要因The global CBRN defense market is estimated to value US$9 billion in 2013, and will increase at a CAGR of 4.2% during the forecast period, to reach US$13.7 billion by 2023. The market consists of five categories of CBRN defense: CBRN detection, CBRN protection, CBRN decontamination, CBRN disposal, and CBRN simulation.
- 商用車用遠隔診療の世界市場2017-2021About Commercial Vehicle Remote DiagnosticsTechnavio defines automotive remote diagnostics or remote vehicle diagnostics as a solution that enables automation of vehicle health and diagnosis using a wireless network. Vehicle health check refers to monitoring vehicle performance by continuously checking and assessing real-time data of certain parameters. This process helps to identify any deviation …
- 世界における小型自動車用材料市場（2008-2028）This latest just-auto report edition offers a global review of the OE material trends sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE material trends market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and …
